The study says the MMR vaccine can protect against Code 19

The study says the MMR vaccine can protect against Code 19

WASHINGTON: The measles-mumps-rubella (MMR) vaccine may provide protection against covid 19, according to a study, which may explain why the disease rate in children and mortality rates are much lower than in adults. Is.
The MMR vaccine has been developed to protect against covid-19, and the study, now published in the journal MBU, provides further evidence that mumps IGG titers, or IGG The severity of antibody levels is inversely related to the recovery. Covid 19 patients had previously been vaccinated with MMR II.
The researchers said that MMR II had measles strain, germinal (B level) mumps strain, and rubella strain RA 27/3 strain.
“We have found a significant inverse relationship between the level of mumps titer in people under the age of 42 and the statistic of covid 19 intensity,” said Jeffrey E. Gold, president of the World Organization in Georgia.
“This leads to an increase in other associations that are showing that the MMR vaccine may be protective against covid-19. It may also explain why children have a higher prevalence of covid-19 than adults,” Gold said. As well as being low, the death rate is also very low. ” He added that most children get their first MMR vaccination between the ages of 12 and 15 months and the second between the ages of 4 and 6.
The researchers divided the 80 articles into two groups. The MMR II group consists of 50 American-born subjects who will receive MMR antibodies primarily from the MMR II vaccine.
The comparative group of 30 subjects had no record of MMR II vaccination, and would consist primarily of MMR antibodies from other sources, including pre-existing measles, mumps and / or rubella. Were
The researchers found a significant inverse relationship between mumps titers and coveted 19 intensity within the MMR II group.
He said there was no significant correlation between mumps titers and disease severity in the comparison group, between mumps titers and age in the MMR II group, or between severity and measles or rubella titers in any group.
Within the MMR II group, mumps titers of 134 to 300 AU / mL were found only in people who were practically immune or asymptomatic, according to the researchers. All people with mild Covid-19 symptoms have mumps below 134 AU / ml.
Everyone with mild symptoms has mumps less than 75 AU / ml. Everyone who was hospitalized and needed oxygen has mumps below 32 AU / ml.
“This is the first immunological study to examine the relationship between the MMR II vaccine and CoVID-19. Including which further investigation is guaranteed. ” Author David J. Hurley Professor and Molecular Microbiologist at the University of Georgia.
“The MMR II vaccine is considered a safe vaccine with very few side effects. If it is used to prevent infection with Covid-19, to prevent the spread of Covid-19, to reduce its severity, or to prevent any other. The compound has the ultimate benefit. In all of this, it’s a very high reward low risk ratio intervention, “Hurley said.
He added: “Maximum serpentine can be achieved with two vaccines for a minimum of 28 days. According to our research, it would be wise to vaccinate people over the age of 40, even if Whether or not they already have high serum MMR titers. ”

STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ

Leave a Reply

Your email address will not be published. Required fields are marked *